Now with over 5,500 members from all over the world, EASL is an influential international organisation. It attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education, and promoting changes in European liver policy.
Leadership & Governance
Management Committee
The Management Committee is the body which advises the Governing Board, prepares the Governing Board’s agenda and discussions and oversees the implementation of the strategy and decisions of the General Assembly and the Governing Board, that are not exclusively covered by the Scientific, the Educational or the Policy, Public Health and Advocacy Committees.
The Management Committee is constituted of:
Secretary General
Aleksander Krag
MD, PhD, MBA, Professor and Head of Hepatology, Odense University Hospital, DenmarkVice-Secretary
Debbie Shawcross
Institute of Liver Studies, King’s College LondonTreasurer
Massimo Pinzani
MD, PhD, FRCPScientific Director UPMC ISMETT Palermo, Italy and Emeritus Professor of Medicine University College London, UK
Chair of the Scientific Committee
Ana Lleo
Professor of Internal Medicine in Humanitas University, Milan, Italy.Educational Councillor
Sven Francque
Chairman of the Department of Gastroenterology and Hepatology of the University Hospital Antwerp and Full Professor of Medicine at the Faculty of Medicine and Health Sciences of the University of AntwerpPublic Health Councillor
Shira Zelber-Sagi
Head of the School of Public Health, University of Haifa, IsraelExternal Affairs Councillor
Francesco Paolo Russo
Associate Professor of Gastroenterology at the University of PaduaInternal Affairs Councillor
Ahmed Elsharkawy
Queen Elizabeth Hospital, Birmingham, United KingdomExecutive Director
![](https://easl.eu/wp-content/uploads/2018/10/Ben-Hainsworth_optimised_IMG_1656.1.jpg)
![](https://easl.eu/wp-content/uploads/2018/10/Ben-Hainsworth_optimised_IMG_1656.1.jpg)